Regeneron Pharmaceuticals

REGN13F as of Jun 30, 2026 · next update ~Nov 14

Who's buying REGN

Top funds mostly added to Regeneron Pharmaceuticals in Q2 (Apr⁠–⁠Jun)

Buying:

Funds2InsidersCongress1

Top funds
2 of 3 bought more, 1 sold some. Largest: Dodge & Cox, $3.0B (2% of its portfolio).
Insiders
No buys, 16 sales in 12 months.
Congress
1 member bought (1 trade), 0 sales in 12 months.

3 funds$3.2B held3.0% avg. weightQ2: 2 bought / 1 sold

13F reports are a snapshot as of Jun 30, 2026; funds may have traded since. Insiders often sell for personal reasons (taxes, diversification, planned sales).

Share price · market data, not from 13F reports

Q2 2026

Insider trades (Form 4)

Last 2 years · 16 filings

Date	Insider	Type	Shares	Price	Value
Oct 14, 2026	Andrew J Murphy	Sold	4,147	$772.70	$3.20M
Sep 2, 2026	Marion Mccourt VP	Sold	2,346	$853.56	$2.00M
Sep 2, 2026	Kathryn Guarini Director	Sold	400	$850.00	$340K
Aug 10, 2026	Kathryn Guarini Director	Sold	400	$800.00	$320K
Aug 10, 2026	Huda Y Zoghbi Director	Sold	800	$800.00	$640K
Jul 2, 2026	Arthur F Ryan Director	Sold	200	$650.15	$130K
May 1, 2026	Arthur F Ryan Director	Sold	100	$705.24	$71K
Apr 1, 2026	Arthur F Ryan Director	Sold	100	$777.27	$78K
Mar 2, 2026	Arthur F Ryan Director	Sold	100	$785.50	$79K
Feb 19, 2026	Huda Y Zoghbi Director	Sold	1,638	$781.33	$1.28M
Feb 9, 2026	Jason Pitofsky VP & Controller	Sold	2,036	$778.52	$1.59M
Feb 9, 2026	Arthur F Ryan Director	Sold	100	$778.53	$78K
Jan 7, 2026	Bonnie L Bassler Director	Sold	1,500	$800.00	$1.20M
Nov 20, 2025	Bonnie L Bassler Director	Sold	760	$750.00	$570K
Nov 7, 2025	Jason Pitofsky VP & Controller	Sold	431	$651.43	$281K
Oct 29, 2025	Christine A Poon Director	Sold	6,500	$654.27	$4.25M